The Industry Committee oversees the strategies and activities related to the industry and biotech members of the society. The committee aims to create networking, education and collaboration opportunities by providing a forum for those in industry to meet and discuss areas of interest that are particular to those involved in drug development and taking a product to market.
Kald Abdallah, MD, PhD – Bristol Myers Squibb
Jennifer Gansert, MD, PhD – Amgen
Mary Margaret Huizinga, MD, MPH, FACP – Novartis Pharmaceuticals
Francesco M. Marincola, MD – Kite, A Gilead Company
Giovanni Melillo, MD – AstraZeneca
Zhen Su, MD, MBA – Marengo Therapeutics